 |
 |
PDF
The benefit of active drug trials is dependent on aetiology in refractory focal...
Liimatainen et al. J Neurol Neurosurg Psychiatry.2008;
79:
808-812
|
|
|
|
|
| To view this item, select one of the options below: |
|
|
|
 |
Login via Athens or your institution |
|
|
|
|
Login for journal subscribers |
|
|
|
|
|
|
Subscribe |
|
|
|
|
Buy the article |
|
 |
Pay per Article - You may access this article (from the computer you are currently using) for 2 days. |
|
|
Pay per Issue - You may access this issue (from the computer you are currently using) for 30 days. |
|
|
SitePass - You may access all content in Journal of Neurology, Neurosurgery, and Psychiatry Online (from the computer you are currently using) for 30 days. |
|
|
|
Regain access to an already purchased article if the access period has not yet expired. |
|
|
|
